Blog

Amazon wants a microphone on your wrist. On Oct. 15 it launched Bee Frontier, a $74.99 band you wear on your wrist or clip to your shirt. It listens to your conversations and hands back summaries, reminders and to-do lists. It’s on sale now. A phone-mounted sibling, Bee Eclipse, is “coming soon” at $99.99.

“They listen to your whole day,” Amazon devices chief Panos Panay said at TechCrunch Disrupt, Reuters reported. Panay pitched it as a way to stay present instead of scribbling notes.

The hardware, per Amazon: two microphones with noise filtering, up to seven days of battery, IP67 water resistance, USB-C charging, one button and a light that shows when it’s on. The Eclipse sticks magnetically to the back of your phone, claims 21+ days of battery, and prompts you to get permission from people on a call every time you start recording.

Here’s the part to read twice. Bee can connect to Alexa+ and to Amazon.com, where Amazon says the items you mention can turn up as product recommendations on its homepage. Say “we need dish soap” out loud, and that might be the next thing Amazon shows you.

Amazon’s privacy pitch: audio is processed in real time and then deleted, never stored, and transcripts are encrypted with keys only your device controls. Reuters says the free tier keeps your data 14 days, and keeping it longer costs about $12 a month. Reuters also noted Amazon took heat in 2019 over people listening to Alexa recordings and faces a class action over it, which Amazon denies.

What to do:

• Tell people when it’s on. It hears everyone around you, not just you. Ask first.
• Leave the Amazon.com connection off unless you actually want your small talk turning into shopping suggestions.
• Use the auto-off setting so it shuts down after a stretch of silence, and delete the transcripts you don’t need.

Source: Amazon — Bee Frontier and Bee Eclipse, Oct. 15, 2026; Reuters via Investing.com — Amazon launches two new portable AI listening devices, Oct. 15, 2026

The fitness band is back with a vengeance. Google announced the Fitbit Edge on Oct. 12 — a slim screen tracker that slots between the $100 Fitbit Air and the Pixel Watch 5, which starts at $350. Price: $179.99. Preorders are open now, and it hits shelves Oct. 27.

Here’s what you get for the money, per Google and Ars Technica:

• A 1.34-inch OLED touchscreen with 46% more viewing area than the old Charge 6, plus one physical button.
• Built-in GPS, so you can leave the phone home on a run, plus an ECG app, blood-oxygen, skin-temperature and heart-rate sensors.
• Up to seven days of battery. Turn on always-on display and Ars says that drops to about two.
• Works with Android or iPhone through the Google Health app, and it’s water-resistant to 5 ATM.

Now the fine print, Ars Technica style: no NFC, so no Google Wallet tap-to-pay. No microphone or speaker, so replies are canned quick responses and there’s no talking to Gemini. You can’t download extra apps or watch faces. And the Gemini-powered Health Coach needs Google Health Premium: three months free, then $10 a month. Google also touts “Health Guardian” trends for blood pressure and insulin resistance, but its own fine print says those are wellness info, not a diagnosis.

One win for your wallet down the road: Google calls it its first repairable tracker, with a replaceable battery. That means a service swap, not a DIY job.

What to do: If you’re still wearing an aging Charge, this is the upgrade Google built for you. If you want to tap to pay or talk to your wrist, spend more on a real smartwatch. And put a calendar reminder on that free Premium trial before it starts billing.

Source: Google — Google Fitbit Edge, Oct. 12, 2026; Ars Technica — Google announces the Fitbit Edge, Oct. 12, 2026

Apple’s first foldable phone didn’t even make it to breakfast. iPhone Duo preorders opened at 5 a.m. Pacific (7 a.m. Central) on Friday, Oct. 16, and within minutes delivery dates slid from Oct. 23 into November. By 5:30 a.m. Pacific, Apple’s online store was quoting Jan. 25, 2027 — for every color and every storage size, MacRumors reported.

Apple told the Financial Times demand has been “nothing short of extraordinary.” Prices run from $1,999 (256GB) up to $3,199 for 2TB. The lucky first orders still land on Oct. 23. Everybody else who ordered from Apple is waiting until next year — so if a Duo was on your Christmas list, Apple’s own store can’t get it there.

Don’t plan on strolling into a store, either. Apple retail staff told MacRumors they’ve been advised there will likely be no walk-in stock on launch day and to discourage customers without preorders from coming in. Apple’s site says to check back Oct. 24 for store pickup.

And the scalpers? Already feasting. Tom’s Guide spotted an eBay buyer paying $3,777 for a 1TB Duo and another paying $4,999 for a 2TB model — on Friday morning, before a single phone shipped.

What to do if you want one:

• Check carriers and retailers, not just Apple. On Friday Tom’s Guide saw earlier dates elsewhere — Best Buy as early as Nov. 3 on some carrier-tied 1TB/2TB models, AT&T around Nov. 9, Verizon around Nov. 14. Those dates move fast.
• Don’t pay a scalper. MacRumors notes Apple has sometimes shipped constrained iPhones sooner than first quoted. No guarantees, but a 2027 date isn’t carved in stone.
• Check pickup on Oct. 24 instead of camping out on launch day without a preorder.

Foldables just went mainstream — and mainstream means a line.

Source: MacRumors — Apple Calls iPhone Duo Demand ‘Extraordinary’ After Orders Slip to 2027, Oct. 16, 2026; MacRumors — iPhone Duo is Sold Out for Christmas, Oct. 16, 2026; Tom’s Guide — iPhone Duo pre-orders live, Oct. 16, 2026

If you were hoping this was the weekend to finally lock a mortgage, the bond market has bad news.

The rate. Freddie Mac says the average 30-year fixed mortgage was 7.40% for the week ending Oct. 15, unchanged from the week before. A year ago it was 6.27%. The 15-year fixed averaged 6.71%, down slightly from 6.73%. Realtor.com calls it a three-year high.

Blame the 10-year. Mortgage rates track the 10-year Treasury yield, and that yield is still above 5%. WSJ market data shows it closed Friday, Oct. 16, at 5.085%. It closed at 5.237% on Oct. 9, so the bond market rallied this week. TreasuryBonds.com reported weekly yield drops of 5 to 16 basis points across maturities. The 52-week high is 5.368%, set Oct. 7. Rates have barely backed off that peak.

Inflation is the problem. September CPI came in at 3.7%, up from 3.4% and above forecasts. Core CPI rose to 2.6% from 2.4%, a sign that price pressure is spreading beyond gas. Realtor.com economist Jiayi Xu said the core reading “reinforces the case for another rate hike by December and could set the stage for additional hikes in early 2027.” Realtor.com puts the federal funds rate at 3.75%–4% after September’s hike. Friday’s jump in oil to nearly $110 doesn’t help.

What it’s doing to housing. According to Realtor.com:

• Pending home sales plunged in September as buyers backed off.
• The share of listings with price cuts hit a four-year high in September.
• For-sale inventory grew nearly 7% from a year ago, the fastest growth since February. Senior economist Anthony Smith says that’s unsold homes piling up, not a wave of new sellers.
• New listings fell 5.1% year over year.
• The median asking price slipped 2.3% to $415,000.

The upside, if you can find one: motivated sellers are negotiating. Xu’s advice is to “rate-proof” your budget so you’re ready when the right house shows up.

For now, buyers are stuck with high rates, and so are sellers who don’t want to give up the cheap mortgage they already have. Until inflation cools, the vise stays tight.

Sources: Freddie Mac: Mortgage Rates Hold Steady at 7.40% · Realtor.com: Mortgage Rates Hold Steady at 3-Year High · WSJ: U.S. 10 Year Treasury Note market data · TreasuryBonds.com: Treasuries End the Week Higher, But Oil Made Friday a Fight

Featured image: editorial illustration by Bugle Blast.

The six biggest U.S. banks reported third-quarter results this week. The quick version: the chaos paid the traders, and the dealmakers got nervous.

JPMorgan blinked. The nation’s biggest bank earned $15.3 billion, or $5.57 a share, up 6% from a year ago. Analysts expected about $5.85, according to LSEG. Reuters says it was JPMorgan’s first profit miss since late 2023. The quarter included $658 million of investment-securities losses; without them, EPS would have been $5.75. Investment-banking fees fell 8% from the second quarter, and fixed-income trading slipped 4%. Equity-markets revenue, though, jumped 49%. JPMorgan also raised its full-year interest-income forecast to roughly $106.2 billion, and it raised its expense forecast to about $108.6 billion.

Goldman feasted. Goldman Sachs earned $5.29 billion, or $17.01 a share, up 29%. Revenue rose 23% to $18.68 billion, its second-best quarter ever. FactSet’s consensus was $12.86 a share, MarketWatch reported. Equities trading drove it.

Morgan Stanley piled on. Equity trading revenue hit about $5.8 billion, up nearly 41%. EPS of $3.03 beat the $2.91 estimate, Reuters reported. Fixed-income trading fell 7.3%.

Citi and Wells. Citigroup earned $5.2 billion, or $2.85 a share, on $23.8 billion of revenue, its best third quarter in a decade. Wells Fargo earned $1.87 a share, above estimates, but its $21.87 billion in revenue missed. Wells CFO Mike Santomassimo said the big jump in the 10-year yield had an effect on activity.

BofA paid the fine. Bank of America’s profit fell 17% to $6.9 billion. It took a $1.2 billion non-tax-deductible charge tied to regulatory penalties over anti-money-laundering and sanctions compliance, which cost 17 cents a share. Its fixed-income trading revenue fell 17%.

The big picture. Reuters says the deal and trading boom behind record first-half earnings may be slowing, as a “grinding bond market rout” and stock swings weighed on activity, especially in late September. Executives still described a strong deals pipeline, and they said consumers and businesses remain in good shape.

So the war, the rate scare and the AI jitters made fortunes on the equity desks while clients sat on their hands. Wall Street got paid for the fear this time. The real test is whether the dealmakers come back.

Sources: Reuters (via Investing.com): JPMorgan posts rare profit miss · JPMorganChase 3Q26 earnings release (SEC) · MarketWatch: JPMorgan, Goldman profits jump as banks kick off earnings · Reuters (via Investing.com): Morgan Stanley beats on equity trading · CNBC: Bank of America Q3 2026 earnings · Reuters (via Yahoo Finance): Wall Street banks see deals slow

Featured image: editorial illustration by Bugle Blast.

Saturday Money Special, and the headline writes itself: oil just touched $110 a barrel for the first time since May, and the stock market got mugged on the way out the door Friday.

The numbers. Brent crude futures settled up $3.94, or 3.7%, at $109.86 on Friday, Oct. 16. That’s the highest close since May 19, Reuters reported. U.S. West Texas Intermediate jumped $3.44, or 3.5%, to $101.41, its first trip back over $100 in about a month. For the week, Brent rose 4.9% and WTI rocketed 10.4%.

What lit the fuse. Pick a front:

• Hormuz: Reuters says attacks around the Strait of Hormuz surged over the past 10 days. Iran says it is stepping up strikes in response to the U.S. blockade of its ports and new sanctions. Kpler analysts said intensified Iranian attacks drove Gulf crude flows “sharply lower.”
• The Saudi bypass: A Saudi-led coalition said it intercepted a ballistic missile fired toward Yanbu, the Red Sea port Saudi Arabia relies on to route oil around Hormuz. Rapidan Energy Group said initial reports showed no damage. Traders also chased unverified rumors of attacks on Saudi energy infrastructure.
• Russia: Ukraine hit Russia’s Ryazan refinery, which suspended a primary crude unit, according to industry sources cited by Reuters. Diesel futures rose more than 1%, NBC News reported. Diesel matters for farms, trucks and factories, and its price has climbed faster than gasoline’s.

The bill came due on Wall Street. NBC News says tech stocks shed more than $1 trillion in value Friday. The Nasdaq 100 fell 2.5% and now sits about 7% below the record it set just last week. The S&P 500 lost 1%. The Philadelphia semiconductor index dropped 3.8%, its eighth straight losing day and its longest losing streak since 2008. Data-center names Nebius and CoreWeave were the Nasdaq 100’s two worst performers.

The emergency barrels aren’t winning yet. The International Energy Agency agreed Thursday to release more than 20 million barrels of fuel. On Friday the U.S. Energy Department asked for proposals to exchange up to 17 million barrels of crude from the Strategic Petroleum Reserve. Prices rose anyway.

Why your wallet cares. The Fed already raised rates by a quarter point in September to fight energy-driven inflation. NBC notes that higher oil makes another hike this year more likely. Wells Fargo analyst Mason Mendez warned that rebuilding depleted global inventories in 2027 “could create an additional source of demand and keep energy prices elevated for longer.”

Translation: the pump, the diesel bill and your 401(k) all took a hit this week, and nobody is promising it’s over.

Sources: Reuters (via Investing.com): Oil touches $110 a barrel for first time since May · NBC News: Tech stocks erase $1 trillion of wealth as oil surges to $110 · WSJ: Oil Prices Rise as Ukraine Renews Attacks on Russian Refineries

Featured image: editorial illustration by Bugle Blast.

Scientists just used AI to invent molecular scissors from scratch — enzymes that find a protein sequence you choose and cut it.

David Baker of the University of Washington and colleagues designed cysteine and zinc proteases de novo, Phys.org reported Oct. 16, citing two papers in Nature. The pipeline stacked an RFdiffusion2 variant called RFD2-MI for 3D shapes and backbones, ProteinMPNN / EnhancedMPNN for sequences, and AlphaFold 3 to check the folds.

They tested the designs in bacteria: each enzyme linked to a target sequence plus a glowing marker. Success meant the enzyme cut the target and freed the marker. For cysteine proteases, 13 of 69 candidates worked. For zinc proteases, 36% of 135 candidates cut matching peptide targets. AI refinement then boosted the top zinc protease’s cutting speed 30×, and a cysteine design cut at precisely the intended site.

Therapeutic promise — not clinical trials yet — showed up in the lab: one design cut full-length TDP-43 (the protein that builds up in ALS and some dementias); others cut amyloid-beta fragments linked to Alzheimer’s and serum amyloid A tied to systemic amyloidosis.

The team’s verdict, as reported: “Our results show that de novo enzyme design has advanced well beyond model reactions on activated substrates.” And: “The ability to design selective proteases for prescribed epitopes on proteins could be transformative for many potential applications.”

The papers: Anqi Chen et al., Computational design of metalloproteases (DOI 10.1038/s41586-026-11167-2); Hojae Choi et al., De novo design of cysteine proteases (DOI 10.1038/s41586-026-11143-w).

Custom scissors for the proteins that make people sick. It’s early, but Nature just put two stamps on it.

Sources: Phys.org — AI molecular scissors that cut proteins · Nature — Chen et al., Computational design of metalloproteases · Nature — Choi et al., De novo design of cysteine proteases

Featured image: AI-generated editorial illustration by Bugle Blast.

SpaceX just put a date on the calendar — and for pre-IPO holders, that date starts the big unlock clock.

On Oct. 16, SpaceX said it will post third-quarter 2026 financial and operational results after market close on Tuesday, Oct. 20, 2026. The company will host a live audio-only webcast at 3:30 p.m. Central / 4:30 p.m. Eastern the same day at ir.spacex.com, livestreamed on X at @SpaceX, with a Q&A platform for pre-submitted questions. The IR release has no revenue numbers and no guidance — just the schedule.

Here’s why the date matters beyond the print. FinanceFeeds, citing the prospectus lock-up schedule, reports that the largest remaining standard lock-up tranche is roughly 28% — up to about 1.3 billion shares — eligible on the second full trading day after Q3 results for the quarter ended Sept. 30, 2026. With results after the close Tuesday, Oct. 20, that second full trading day lands roughly on Thursday, Oct. 22 (Wednesday the 21st is the first full trading day after the print; Thursday the 22nd is the second).

Separately, a day-135 window of up to about 328.4 million shares is tied to Oct. 24 — a Saturday — so the first tradable session typically follows on Monday.

No price targets, no invented stock moves, no fantasy revenue: just a company pinning Q3 and a lock-up calendar that suddenly has a concrete start gun. Pre-IPO holders have been waiting for that gun. Now they have a date to circle.

Sources: SpaceX IR — SpaceX to Post Third Quarter 2026 Results and Host Webcast on October 20, 2026 · FinanceFeeds — SpaceX lock-up schedule for pre-IPO holders

Featured image: AI-generated editorial illustration by Bugle Blast.

Five days. That’s how long Katie Zacharia lasted as White House press secretary — and now she’s out.

Senior administration officials confirmed Friday that Zacharia is leaving the podium job and transitioning into a new role to be announced later, NBC News, CBS News, the Associated Press, The Washington Post and Politico reported. She had succeeded Karoline Leavitt, who left at the end of August after serving since the start of Trump’s term in January 2025.

Trump announced the appointment the previous Friday. Her first briefing came Tuesday morning after the holiday weekend. It lasted under 15 minutes, with few questions. She couldn’t say whether the United States had stopped sharing intelligence with Ukraine. During that same briefing, after a reporter asked about misconduct allegations, she announced Trump had asked Kimberly Guilfoyle to resign as U.S. ambassador to Greece. Guilfoyle denied the allegations and stepped down within hours.

Then the scrutiny hit. The Wall Street Journal first reported she had represented herself as a lawyer but had not passed the California bar. A senior administration official confirmed it Thursday. Zacharia told Jack Posobiec Thursday she hadn’t passed. She’s a Pepperdine Law graduate who said she practiced law in China; NBC found no evidence she was licensed in any state, and experts say only Chinese citizens can sit for the Chinese bar. The Campaign for Accountability filed a complaint with the California State Bar.

Earlier Friday, Trump said the media treated her “nastily,” told her she doesn’t have to do this, and said he would let her decide. He added that if he were her he’d “reconsider,” and mentioned her “beautiful husband and family.”

The tenure is shorter than Anthony Scaramucci’s 11 days as White House communications director in the first term. Scaramucci posted: “Records are made to be broken. But I take no please in other people’s pain.”

The exit leaves a vacancy less than three weeks before the midterms, with Trump already complaining about bad PR. Sources say she was still scheduled for dinner Friday with Vice President JD Vance’s family at the Naval Observatory.

Sources: NBC News — White House press secretary Katie Zacharia out after 5 days · AP — Katie Zacharia out as Trump press secretary · CBS News — Trump’s Katie Zacharia White House press secretary

Featured image: AI-generated editorial illustration by Bugle Blast.

Opioids are the strongest painkillers we have, and they hit the whole body to get there: the brain, the gut, the breathing center. A team of chemists just gave morphine an on/off switch, and the switch is a flashlight.

In a study published Oct. 15 in Cell, researchers led by Weill Cornell Medicine and the University of Pennsylvania describe AM-3, a morphine-based compound that changes shape depending on the light that hits it. Under near-ultraviolet light, it strongly activates the mu-opioid receptor, the main target of opioid painkillers. Under blue light, it backs off. It can flip back and forth over and over.

The payoff: inject it, shine a brief burst of UV on the sore spot, and you get morphine-like relief just there. In mouse models, including bone cancer pain and visceral pain, the team saw reduced or no signs of tolerance, constipation and other side effects. AM-3 also has trouble getting into the brain, which helps keep addiction and breathing suppression in check.

“We think this is a significant breakthrough not just for pain management but also for the general strategy of photopharmacology,” said co-senior author Joshua Levitz of Weill Cornell. Penn chemist Dirk Trauner, the other senior author, said the goal is to make opioids safer “by controlling them with light in the periphery.” The trick borrows from the eye, where light flips the shape of retinal to trigger vision, C&EN reports.

The stakes: the Cornell team cites CDC data showing more than 40,000 Americans died last year from overdoses involving opioids.

The catch: UV light can damage eyes and skin, and this is still preclinical work in mice. The team is building successor molecules that switch with safe visible light, ideally red light that penetrates deep into tissue, and hopes to reach clinical trials eventually. “We have some exciting preliminary results already,” Trauner said.

Pain relief where you point it, and as little as possible everywhere else. It’s early, but it’s a real attack on what makes opioids dangerous.

Sources: Cornell Chronicle / Weill Cornell Medicine — Light-activated opioid painkiller may work without dangerous side effects · C&EN — A light-activated morphine derivative relieves pain in mice

Featured image: AI-generated editorial illustration by Bugle Blast.